Constanze SchmiesGroup Leader QC at Bachem AGSpeaker
Profile
Constanze Schmies, PhD is Group Leader QC Early Phase at Bachem AG, where she has been working since 2020. She holds a PhD in Pharmacy from the University of Bonn, Germany, and has a background in Molecular Life Sciences from Radboud University Nijmegen, the Netherlands. In her current role, she leads a team responsible for analytical method development for oligonucleotide New Chemical Entity (NCE) projects, as well as release testing and stability studies. Her expertise focuses on quality control and analytical characterization of innovative oligonucleotide therapeutics throughout early-phase development.
Agenda Sessions
Comprehensive Analytical Strategies in Oligo CMC: Navigating Complexity from Early Development to Final Release
, 11:50amView Session

